LTUS: well written article, Edward. LTUS is my top pick in chinese pharmas. The CEO has never disappointed investors and hopefully the SP will begin to reflect their achievements. The CEO also has stated that he has no interest in issuing shares (diluting) here and will finance company growth with free cash flow from operations.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.